Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Lancet. Infectious Diseases|October 7, 2011
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trialsJulie E Ledgerwood, Chih-Jen Wei, Zonghui Hu, et al.
Lancet (London, England)|August 19, 2014
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trialLee-Jah Chang, Kimberly A Dowd, Floreliz H Mendoza, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
NPJ Vaccines|December 22, 2017
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trialAdam D DeZure, Emily E Coates, Zonghui Hu, et al.
The Journal of Infectious Diseases|March 14, 2013
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoireJoseph P Casazza, Kathryn A Bowman, Selorm Adzaku, et al.
Lancet (London, England)|December 27, 2014
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trialHannah Kibuuka, Nina M Berkowitz, Monica Millard, et al.
The New England Journal of Medicine|November 27, 2014
Chimpanzee Adenovirus Vector Ebola VaccineJulie E Ledgerwood, Adam D DeZure, Daphne A Stanley, et al.
The New England Journal of Medicine|October 9, 2013
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccineScott M Hammer, Magdalena E Sobieszczyk, Holly Janes, et al.
Science Translational Medicine|December 25, 2015
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infectionRebecca M Lynch, Eli Boritz, Emily E Coates, et al.
Pageof 4